Location History:
- Bethesda, MD (US) (2011)
- Washington, DC (US) (2014)
Company Filing History:
Years Active: 2011-2014
Title: Innovations of Alessio Giubellino
Introduction
Alessio Giubellino is a prominent inventor based in Washington, DC. He has made significant contributions to the field of biomedical research, particularly in the area of cancer treatment. With a total of 2 patents, his work focuses on innovative methods to inhibit specific cellular processes that contribute to cancer progression.
Latest Patents
Giubellino's latest patents include compositions and methods for the inhibition of hepatocyte growth factor receptor c-Met signaling. This invention provides derivatives and analogs of inhibitors of receptor tyrosine kinase c-Met, along with pharmaceutical compositions containing these derivatives. The methods outlined in this patent aim to inhibit cell motility, angiogenesis, and metastasis, particularly in the context of metastatic cancers such as melanoma and prostate cancer. The invention also details methods of blocking HGF, VEGF, or bFGF-stimulated migration, cell proliferation, and the formation of capillary-like structures.
Career Highlights
Alessio Giubellino is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on groundbreaking research that has the potential to impact cancer therapies significantly.
Collaborations
Throughout his career, Giubellino has collaborated with notable colleagues, including Donald P Bottaro and Terrence R Burke, Jr. These collaborations have further enriched his research and contributed to the advancement of innovative cancer treatment methodologies.
Conclusion
Alessio Giubellino's contributions to the field of cancer research through his patents and work at the National Institutes of Health highlight his commitment to developing effective therapies. His innovative approaches continue to pave the way for advancements in cancer treatment.